Teladoc Health appointed Michael Smith to its board, enhancing leadership with his extensive financial and strategic experience.
Quiver AI Summary
Teladoc Health has appointed Michael Smith to its board of directors, bringing over 30 years of experience in financial management and strategic transformation. This appointment follows the retirements of board members Eric Evans and Thomas McKinley. Smith, who will serve on the audit and nominating committees, previously held roles as Vice Chair and Chief Financial Officer at Voya Financial and has extensive experience at Lincoln Financial. His expertise in enterprise transformations aligns with Teladoc's mission to innovate in virtual care. Smith expressed enthusiasm for contributing to the company's vision of enhancing healthcare through technology. Teladoc Health is set to announce its fourth quarter 2025 results on February 25, 2026.
Potential Positives
- The appointment of Michael Smith to the board of directors brings extensive leadership experience in financial management and strategic transformation, which may enhance the company's governance and long-term growth strategies.
Potential Negatives
- Appointment of Michael Smith follows the retirements of two board members, which may raise concerns regarding board stability and continuity in leadership.
- Company has not disclosed any information regarding the performance or issues faced by the outgoing board members, which could leave investors questioning the reasons for their departures.
- Upcoming fourth quarter results release may indicate potential financial challenges, especially as it follows a significant leadership change.
FAQ
Who is Michael Smith and what is his new role at Teladoc Health?
Michael Smith is the newly appointed director on Teladoc Health's board, with extensive experience in financial management and strategic transformation.
What experience does Michael Smith bring to Teladoc Health's board?
Mr. Smith brings over 30 years of leadership experience in financial management and enterprise transformations, particularly in regulated markets.
When will Teladoc Health release its fourth quarter 2025 results?
Teladoc Health will release its fourth quarter 2025 results on February 25, 2026, after the market closes.
What is Teladoc Health's mission?
Teladoc Health's mission is to transform high-quality care using technology, enabling better health outcomes for patients.
How can I contact Teladoc Health's investor relations?
You can reach Teladoc Health's investor relations at [email protected] for inquiries.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TDOC Insider Trading Activity
$TDOC insiders have traded $TDOC stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $TDOC stock by insiders over the last 6 months:
- CHARLES III DIVITA (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 2 sales selling 33,925 shares for an estimated $258,271.
- FERNANDO M. RODRIGUES (President of BetterHelp) has made 0 purchases and 4 sales selling 13,065 shares for an estimated $98,451.
- MALA MURTHY (CHIEF FINANCIAL OFFICER) sold 12,846 shares for an estimated $97,436
- ADAM C VANDERVOORT (CHIEF LEGAL OFFICER, SECRETARY) has made 0 purchases and 2 sales selling 11,587 shares for an estimated $87,332.
- KELLY BLISS (President, U.S. Group Health) has made 0 purchases and 2 sales selling 9,282 shares for an estimated $69,959.
- KENNETH H PAULUS purchased 10,000 shares for an estimated $69,400
- CARLOS NUENO (President, International) has made 0 purchases and 2 sales selling 7,895 shares for an estimated $59,505.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TDOC Revenue
$TDOC had revenues of $626.4M in Q3 2025. This is a decrease of -2.2% from the same period in the prior year.
You can track TDOC financials on Quiver Quantitative's TDOC stock page.
$TDOC Hedge Fund Activity
We have seen 134 institutional investors add shares of $TDOC stock to their portfolio, and 233 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 3,039,663 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,496,594
- JUPITER ASSET MANAGEMENT LTD added 2,880,008 shares (+293.9%) to their portfolio in Q4 2025, for an estimated $20,160,056
- MAPLE ROCK CAPITAL PARTNERS INC. removed 2,688,278 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $20,780,388
- AMERICAN CENTURY COMPANIES INC added 2,582,227 shares (+509.2%) to their portfolio in Q4 2025, for an estimated $18,075,589
- PALE FIRE CAPITAL SE added 1,944,203 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,609,421
- MORGAN STANLEY removed 1,924,989 shares (-53.5%) from their portfolio in Q4 2025, for an estimated $13,474,923
- CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 1,510,823 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,678,661
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TDOC Price Targets
Multiple analysts have issued price targets for $TDOC recently. We have seen 5 analysts offer price targets for $TDOC in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Daniel Grosslight from Citigroup set a target price of $9.0 on 01/09/2026
- Glen Santangelo from Barclays set a target price of $8.5 on 12/09/2025
- Allen Lutz from B of A Securities set a target price of $8.0 on 11/25/2025
- Sean Dodge from BMO Capital set a target price of $8.0 on 11/13/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $8.0 on 10/30/2025
Full Release
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements of Eric Evans and Thomas McKinley and will serve on the board’s audit and nominating and corporate governance committees.
“Michael's experience leading enterprise transformations makes him a strong addition to the Board,” said Kenneth H. Paulus, the non-executive Chairman of the Teladoc Health board. “As the company continues to scale and innovate, his perspective will be valuable in helping accelerate strategic focus for the company’s next phase of long‑term growth.”
Mr. Smith is the former Vice Chair and Chief Financial Officer of Voya Financial, a leading health, wealth, and investment company, where he played an integral role in the company's transformation from a traditional insurance business to a market leader in retirement, investment and workplace benefits. He held senior executive roles in Actuarial, Finance, Operations and Risk Management during more than 20 years at Lincoln Financial. He currently serves as Executive Chairman of Talcott Financial Group, an international life insurance and risk management firm with $130 billion in assets under management. Mr. Smith holds an undergraduate degree from the University of Michigan, is a Fellow of the Society of Actuaries, and is a CFA ® charterholder.
“Teladoc Health’s mission to transform high‑quality care with technology is more important than ever,” said Smith. “I’m pleased to join the Board and bring my experience leading transformational change and sustainable value creation.”
Teladoc Health will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com .
Investors:
Michael Minchak
[email protected]
Media:
Lou Serio
[email protected]
